Introduction
Interferons (IFN) are a family of cytokines that regulate a broad range of cellular processes and exert antiviral and anticellular eects (Stark et al., 1998) through the induction of a spectrum of genes (Der et al., 1998) . A key regulator of both antiviral and anticellular activities of IFN is the serine-threonine protein kinase dependent of dsRNA, PKR (Clemens and Elia, 1997; Meurs et al., 1990) . PKR regulates translation initiation by phosphorylating the alpha subunit of the eukaryotic initiator factor 2 (eIF2a) (Hershey, 1991; Rowlands et al., 1988) and also is a key signalling mediator of dierent dsRNA-induced pathways (Williams, 1999) . In response to dsRNA, PKR controls the activation of several transcription factors such as NF-kB or IRF-1, (Gil et al., 1999; Kumar et al., 1997; Yang et al., 1995) . In addition, PKR has been proposed to act as a tumour supressor (Koromilas et al., 1992; Meurs et al., 1993) and plays a role in cell growth control (Chong et al., 1992) , cell dierentiation (Petryshyn et al., 1984) , and apoptosis induction Lee and Esteban, 1994) . De®ning the signalling pathway triggered by PKR that drives the cells into apoptosis has been a major interest in the ®eld (Balachandran et al., 1998; Gil et al., 1999; Lee et al., 1997; Srivastava et al., 1998; Yeung and Lau, 1998) . Phosphorylation of eIF-2a by PKR and also transcriptional control at the level of the NF-kB pathway are involved in PKR-induced apoptosis (Gil et al., 1999; Srivastava et al., 1998) . Recently, some PKR targets involved in apoptosis induction have been proposed, such as p53 (Cuddihy et al., 1999a,b; Yeung and Lau, 1998) and Fas (Balachandran et al., 1998; DonzeÂ et al., 1999; Gil et al., 1999; Takizawa et al., 1996; Wada et al., 1995) but evidence establishing the functional relationship between PKR-induced apoptosis and these proteins is limited (Takizawa et al., 1996; Yeung and Lau, 1998) .
Fas is a widely expressed cell-surface receptor belonging to the tumour-necrosis factor (TNF) receptor family Dixit, 1998, 1999) . These receptors transduce extracellular signals to the apoptotic cellular machinery leading to cell death Dixit, 1998, 1999) . The induction of cell death by these receptors begins with the recruitment of adapter proteins, such as the Fas-associated protein with a death domain (FADD) (Ashkenazi and Dixit, 1999; Chinnaiyan et al., 1995) and is followed by the recruitment of a cell death executioner, caspase 8 (Muzio et al., 1996) , a member of the cysteinylaspartate proteases family (Nicholson and Thornberry and Lazebnik., 1998) . Caspases are synthesized as zymogens, and are proteolytically activated either by autoprocessing or by cleavage by other caspases. Caspase 8 occupies an apical position in death receptor pathways of apoptosis, because it associates with the death eector domain (DED) of FADD by homotypic interaction with its two Nterminals DEDs. By this mechanism, caspase 8 has been shown to be speci®cally activated and initiates cell death execution in response to death receptors (Varfolomeev et al., 1998) and not to other stimuli that, in contrast, activate caspase 9 as the initiator caspase Kuida et al., 1998) . Caspase 9 activation occurs through the formation of a complex called apoptosome requiring also Apaf1 and cytochrome c translocated from mitochondria to the cytoplasm Zhou et al., 1997) . Both apoptotic pathways (initiated by caspases 8 or 9) converge in the ®nal activation of terminator caspases (caspases 3, 6, 7) (Thornberry and Lazebnik., 1998) . The targets of the terminator caspases are diverse, varying from structural proteins to enzymes whose activity is regulated by proteolytic cleavage (Thornberry and Lazebnik., 1998) . For example, caspase 3 that is proteolytically activated by initiator caspases of both pathways (caspases 8 and 9) is responsible for cleavage of ICAD , a molecule that under normal conditions inhibits the caspase activated DNase (CAD). Upon ICAD cleavage, CAD is activated and provokes oligonucleosomal DNA fragmentations , one of the hallmarks of apoptosis. Although earlier studies showed that there was functional independence at the initiation level between both caspase cascades, at present we know that apoptosis initiated by caspase 8 also activates the caspase 9 branch of apoptosis through Bid cleavage by caspase 8 . Truncated Bid is a proapoptotic molecule of the Bcl-2 family (Reed, 1997 ) that through its insertion in the mitochondrial membrane causes cytochrome c release from mitochondria to the cell cytoplasm which, in turn, induces formation of the apoptosome complex (Hirata et al., 1998; Zou et al., 1997) The death receptor pathways are used by dierent stimuli to execute apoptosis. For example, upregulation of members of the Fas pathway have also been shown to play an important role in mediating c-myc induced apoptosis (Hueber et al., 1997) . Indeed, interfering with the Fas pathway by blocking antibodies or using cells derived from mice lacking functional Fas (Watanabe et al., 1992) or its ligand (Takahashi et al., 1994) inhibits almost completely apoptosis induction caused by c-myc expression. Fas mRNA is upregulated upon PKR induction (Balachandran et al., 1998; Der et al., 1997; DonzeÂ et al., 1999; Gil et al., 1999; Takizawa et al., 1996) but the role of this upregulation, if any, in PKR-induced cell death is not known. Recently, the in¯uence of the death receptor recruited adapter protein FADD in pICinduced apoptosis has been noted (Balachandran et al., 1998) . However, given the fact that the 2-5A synthetaseRNAse L system that is a dsRNA-induced pathway, is involved in apoptosis (Castelli et al., 1997; DõÂ az-Guerra et al., 1997; Zhou et al., 1997) , and that thymocites derived from RNase L knockout mouse cells have decreased levels of apoptosis in response to Fas and TNF-a treatment (Zhou et al., 1997) , points out that the role of death receptor pathways in PKR-induced apoptosis remains unde®ned. On the other hand, the adapter molecule FADD is involved in mediating cell death induced by several death receptors such as TNFR1, Fas and DR3 (Yu et al., 1996) but not by others like DR4 . Thus, a dissection of the dierent death receptors pathways should be done to clarify their involvement in PKRinduced apoptosis. Recently, several reports have linked FADD activation of caspase 8 with apoptosis induction by diverse agents, such as lipopolysaccaride (Choi et al., 1998) , cycloheximide (Tang et al., 1999) , and anti-cancer drugs (Micheaux et al., 1999; Wesselborg et al., 1999) . However, these studies have failed to link the FADDmediated activation of caspase 8 with any of the known death receptor pathways converging in FADD-dependent apoptosis (Choi et al., 1998) . Additionally, two independent studies (Perez and White, 1998; Siegel et al., 1998) have shown that overexpression of FADD with the ability to recruit caspase 8 is enough to trigger apoptosis, correlating with the formation of FADD-composed perinuclear ®lament structures.
In view of the above observations it is necessary to determine the role of FADD in PKR-induced apoptosis. In this report, we have carried out an in depth examination of the role of molecules in the pathway of death receptors in PKR-induced apoptosis: from FADD, through caspase 8, to terminator caspases. In addition, upstream inducers of FADD were also analysed. From these studies we have identi®ed a series of steps leading to apoptosis induction by PKR, from FADD-dependent initiation through terminator caspases.
Results

PKR overexpression upregulates Fas mRNA transcription
We have previously described an inducible system based on VV recombinants capable of expressing PKR, and other proteins and have shown that expression of PKR in an activated form triggers apoptosis, induces antiviral activity against VV and VSV, and induces translational inhibition and NF-kB activation through the IkB kinase complex (Lee and Esteban, 1994; Lee et al., 1993 Lee et al., , 1996 Lee et al., , 1997 Gil et al., 2000) . Results from using this inducible virus ± cell system have been con®rmed by others with transfected cells or with cells derived from PKR gene knock-out mice Srivastava et al., 1998) . The VV inducible system was also used to identify apoptotic viral genes (Suarez et al., 1996) and cellular and viral inhibitors of apoptosis (Brun et al., 1996; Lee et al., 1997) . In addition, we recently demonstrated that apoptosis induction mediated by PKR involves not only eIF-2a phosphorylation and concomitant control at the translational level, but also transcriptional regulation of the NF-kB pathway (Gil et al., 1999) . However, targets of these and others transcriptional pathways regulated by PKR relative to induction of apoptosis have not been studied. Fas mRNA transcription has been shown to be upregulated by PKR Takizawa et al., 1996) in two other models of PKR-induced apoptosis. Thus, we checked regulation of Fas mRNA levels upon PKR expression in our VV expression system. By RT ± PCR of mRNAs obtained from cells infected with VV PKR or control viruses, we observed that at times as short as 6 h.p.i. there is upregulation of Fas mRNA transcription and this remained high at 8 hpi ( Figure 1 , lanes 3 and 4) as compared with VV infected cells (lanes 1 and 2). Additionally, in VV PKR infected cells in the absence of IPTG and in mock infected cells the levels of Fas mRNA expression were not detectable using our ampli®cation conditions (data not shown). Together, these results suggest that upregulated transcription of Fas gene upon PKR expression could account for apoptosis induction mediated by PKR, and further stimulated an investigation in death receptors' apoptosis pathways.
PKR induces caspase 8 activity upstream of caspase 3 activity
One of the hallmarks of apoptosis induced by death receptors is that caspase 8 is the caspase speci®cally involved in initiation of the caspase cascade in these pathways (Thornberry and Lazebnik, 1998; Varfolomeev et al., 1998) . After this activation, eector caspases such as caspase-3 are activated as ®nal steps of a cascade of caspases activation via a pathway common to apoptosis (Thornberry and Lazebnik, 1998) . To determine if caspase 8 was activated upon PKR expression and if a functional relationship with PKR induced apoptosis could be established, we measured caspase 3 and 8 activities in extracts of cells infected with VV recombinants expressing or not PKR under regulation of IPTG. To measure caspase 3 and 8 activities, we collected cells at dierent times, beginning at 12 h.p.i. and evaluated caspase 8 activity by cleavage of¯uorescent IETD-FMK substrate and caspase 3 activity by DEVD-pNA colorimetric substrate cleavage. Clearly, both caspases, are activated only when PKR is induced and their activity increased with time ( Figure 2 ). Given the fact that caspase 8 activity is linked exclusively to death receptor initiated apoptosis (Varfolomeev et al., 1998) , modulation of death receptor pathways by PKR was suggested. Thus, we next asked if the caspase 8 activity was upstream of caspase 3 activity, as it has been described for apoptosis pathways involving death receptors (Varfolomeev et al., 1998) and if the caspase 8 activity observed was a result of the initiation of the caspase cascade (Hirata et al., 1998) . To address these questions we used a chemical inhibitor of caspase 8 and tested its ability to inhibit both PKR-induced apoptosis and caspase 3 activity triggered by PKR. The chemical inhibitor Z-IETD-FMK is an irreversible and permeable speci®c caspase 8 inhibitor . As shown in Figure 3 , treatment of VV PKR-infected cells with this inhibitor achieved a dosedependent inhibition of apoptosis induced by PKR as measured by cell death ELISA ( Figure 3a ) and caspase 3 activity ( Figure 3b ). The blockage of PKR-induced apoptosis induced by Z-IETD-FMK, was similar to that achieved using a broad range caspase inhibitor (ZVAD-FMK) that is less speci®c and inhibits dierent caspase activities. Interestingly, the fact that caspase 3 activity was abolished upon treatment with the caspase 8 chemical inhibitor indicates that caspase 3 is downstream of caspase 8 in PKR-induced apoptosis, suggesting a functional interaction of PKR with death receptor pathways for initiating apoptosis.
Blocking PKR-induced apoptosis by vFLIP or FADD DN expression
To further de®ne the involvement of molecules in the apoptosis pathway triggered by death receptors involving caspase 8, we subcloned a tagged version of MC159L into the VV insertional vector pHLZ under a synthetic early-late constitutive promoter (VaÂ zquez et al., 1998) . This gene from the poxvirus Molluscum contagiosum (MCV) encodes a viral FLIP homologue (Tschopp et al., 1998a,b) that interferes with the apoptosis pathway triggered by certain death receptors by sequestering FADD (Bertin et al., 1997; Hu et al., 1997; Thome et al., 1997) . We constructed two dierent VV recombinants expressing the MC 159L; one encoding PKR in the same virus genome under an inducible promoter and MC 159L under a constitutive promoter; the other VV recombinant expressed only the MC 159L. In order to test the ability of MC 159L protein to inhibit PKR-induced apoptosis, we infected HeLa cells with rVV expressing PKR alone or together with dierent doses of the MC 159L protein, as shown in Figure 4 . Co-expression of increasing amounts of the MC 159L together with PKR abrogated the capacity of PKR to induce apoptosis as measured both by a caspase 3 assay and by oligonucleosomal cytoplasmic complexes by ELISA (Figure 4b,c) . Expression of the FLIP MCV, inhibits FADD recruitment of caspase 8 (Bertin et al., 1997; Tschopp et al., 1998b) and thus also inhibit PKR-induced apoptosis.
It has been previously shown that expression of a amino terminal deletion mutant form of FADD, lacking the death eector domain (DED) required for interaction with caspase 8, results in a dominant negative mutant that interferes with pathways of apoptosis requiring recruitment of caspase 8 mediated by FADD (Chinnaiyan et al., 1995) . In order to con®rm results obtained with the MCV FLIP homologue, we decided to express the FADD DN mutant by rVV. Using the same strategy described above, we constructed two VV recombinants expressing either FADD DN or co-expressing FADD DN together with PKR under an inducible promoter (Figure 5a ). To test the ability of FADD DN to interfere with PKR-induced apoptosis, we infected HeLa cells with viruses expressing PKR alone or with dierent amounts of a truncated FADD molecule. As shown in Figure 5 , co-expression of increasing amounts of FADD DN together with PKR abrogated the capacity of PKR to induce apoptosis, as measured by a caspase 3 activity assay (Figure 5b) . Thus, the expression of FADD DN, lacking its N-terminal death eector domain (DED), which makes it unable to recruit caspase 8, abolished PKR induced apoptosis. These ®ndings highlight the importance of caspase 8 activation triggered by FADD in PKR-induced apoptosis.
PKR induced apoptosis is not diminished in MEFs lacking a functional Fas receptor
Next we investigated the functional importance of the prototypic member of the death receptor family, Fas receptor, on PKR induced apoptosis. To this aim, we examined if the expression of PKR was able to induce apoptosis in MEFs derived from lpr/ lpr mice ( Figure 6 ). These mice harbour a point mutation in the cytoplasmic region encoded by the Fas gene, that inhibits Fas ability to engage the FADD adapter protein involved in transducing extracellular Fas ligand signal to the cell (Chinnaiyan et al., 1995; Wesselborg et al., 1999) . To evaluate the importance of Fas in PKR-induced apoptosis we infected lpr/lpr MEFs and control MEFs with VV PKR in the absence or presence of IPTG. At dierent times post-infection cells were collected and apoptosis induction was measured. As shown in Figure 6 , expression of PKR was able to induce apoptosis in both MEFs derived from wild type or lpr/lpr mice with similar temporal patterns. Another experiment measuring apoptosis induction at 24 h.p.i. including mock and VV as additional controls, gave similar results (data not shown). From the above ®ndings we conclude that in MEFs a functional Fas receptor is dispensable for commitment of apoptosis induced by PKR. Figure 5 Eect of a truncated FADD dominant negative molecule over PKR-induced caspase 3 activation. (a) Expression of FADD DN and PKR in the same samples used for determining caspase 3 activity. Cells were collected at 24 h.p.i., extracts were lysed and equal amounts of protein as determined by BCA were analysed by SDS ± PAGE in conjunction with Western blotting using anti-PKR and anti-FADD antibodies. (b) Caspase 3 activity assay. Duplicated samples were used for determining caspase 3 activity as explained in Materials and methods 
Fas-FasL and TNFa-TNFR1 interactions are not involved in PKR-induced apoptosis
In order to further characterize the interaction of the Fas-FasL pathway on PKR-induced apoptosis, we used a previously characterized hamster monoclonal antibody directed against mouse Fas ligand that has been shown to block Fas-induced apoptosis (Hueber et al., 1997) . First we tried to block apoptosis induced by PKR expression in control MEFs using a similar concentration of the blocking antibody as previously described (Hueber et al., 1997) , but no inhibition was observed (data not shown). Therefore we used the blocking antibody at a concentration of 10 mg/ml and 30 mg/ml (10-and 30-fold more concentrated, respectively, than the highest concentration used in the previous work). As shown in Figure 7a , no signi®cant reduction was found in PKR-induced apoptosis in antibody-treated cells. Similar results were obtained in 3T3 cells. However in similar conditions the antibody was able to block apoptosis induced by Fas activation (Figure 7a, inset) . This observation further con®rm that the Fas-FasL interaction is not necessary for PKR-induced apoptosis.
Our previous results that PKR-induced apoptosis involves a death receptor-initiated pathway and that blocking the Fas-FasL pathway at both the level of the receptor and the ligand has no eect over PKRinduced apoptosis suggest that another FADD-dependent pathway might be involved in PKR-induced apoptosis. An obvious candidate was the TNFa-TNFR1 pathway. To test this possibility we used a blocking mAb (B13.2) directed against TNFa (Pimentel-MuinÄ os et al., 1994) . Cells were infected with VV PKR in the absence or presence of IPTG. Additional negative controls, such as mock infection or infection with parental VV were included. We con®rmed that B13.2 blocked apoptosis triggered by soluble TNFa (50 ng/ml) in the presence of CHX (Figure 7b inset) . As shown in Figure 7b , mAb B13.2 was unable to block PKR-induced apoptosis, as measured both by a caspase 3-like activity assay and by an DNA fragmentation ELISA assay. As this antibody blocks exogenously added TNFa at the concentrations used in this assay, the above results suggest that neither Fas nor TNFR1 are the death receptors involved in apoptosis induction upon PKR expression.
Discussion
Besides its important role as a translational regulator, PKR is a key mediator in dierent signal transduction pathways (Williams, 1999) . As a result, many cellular processes such as cellular growth (Chong et al., 1992) , dierentiation (Petryshyn et al., 1984) , and apoptosis Lee and Esteban, 1994) are regulated by PKR action. We are specially interested in knowing how PKR induces apoptosis because the elucidation of this pathway will help to explain how PKR exerts its various biological eects. In this work, the functional interaction between PKR and death receptor pathways of apoptosis was characterized.
In the ®rst report of apoptosis induction by PKR (Lee and Esteban, 1994) , it was believed that this activity was the result of translational inhibition induced through PKR phosphorylation of eIF2a. However, although a role for this translational event has been clearly demonstrated (Gil et al., 1999; Srivastava et al., 1998) , the involvement of transcrip- Figure 7 Eect of blocking antibodies against FasL and TNFa over PKR-induced apoptosis. (a) MEFs derived from a control mouse were grown in 12-well plates infected (5 p.f.u. cell) with VV PKR when indicated, and PKR expression induced by adding 5 mM IPTG after 1 h of viral adsorption. A hamster anti mouse FasL antibody was added after 1 h of viral adsorption at indicated concentrations. At 24 h.p.i. cells were processed and an ELISA for oligonucleosomal cytoplasmic determination was performed. As a control experiment (inset), cells were preincubated for 1 h with the antibody (+Ab, 10 mg/ml) when indicated, and then soluble FasL (25 ng/ml) was added. Results represented triplicate samples from two independent experiments and were repeated with similar results in 3T3 cells. (b) HeLa cells were grown in 12-well plates infected (5 p.f.u. cell) with VV PKR where indicated, and PKR expression induced by adding 5 mM IPTG after 1 h of viral adsorption. A neutralizing anti-TNFa monoclonal antibody was added after 1 h of viral adsorption at indicated concentrations. At 24 h.p.i. cells were processed and an ELISA for oligonucleosomal cytoplasmic determination was performed. As a control experiment (inset), cells were pretreated with CHX (100 mg/ml) in the presence or absence of 50 mg/ml of the antibody (+Ab or 7Ab) and 1 h later TNFa (50 ng/ml) was added. Results represent triplicate samples from two independent experiments tional regulatory mechanisms on apoptosis induced by PKR in apoptosis has also been shown (Balachandran et al., 1998; Gil et al., 1999; Yeung and Lau, 1998) . Given the current knowledge of apoptosis pathways, we asked the question of which of the initiator caspases is involved in PKR-induced apoptosis. The results presented in this study demonstrate that caspase 8 is activated during PKR-induced apoptosis and that by speci®cally inhibiting this caspase, downstream events leading to apoptosis, such as caspase 3 activation and subsequent DNA fragmentation induced by caspase 3 (Woo et al., 1998) are inhibited (Figure 8) .
We have used two complementary strategies to con®rm results obtained from chemical inhibition of caspase 8. One was based on analysis of apoptosis in response to expression of a truncated form of FADD, lacking the N-terminal DED, but with an intact Cterminal death domain (DD) that serves to recruit FADD to cytoplasmic DDs of dierent death receptors. By targeting the FADD molecule we blocked PKR-induced apoptosis, thus con®rming a role of death receptor pathways in PKR-induced apoptosis. The other strategy was expression of a viral FLIP analogue (Irmler et al., 1997; Tschopp et al., 1998a,b) , MC 159L. This protein contains two death eector domains (DED) by which MC 159L binds to the DED of FADD (Bertin et al., 1997) , thus sequestering this adapter molecule and avoiding interaction of FADD DED with DEDs of caspase 8. Thus, activation of the caspase cascade is inhibited at the level of initiation (Bertin et al., 1997) . As shown in Figure 4 , expression of MC 159L was by itself sucient to avoid downstream events in PKR-induced apoptosis, further demonstrating the functional interaction of caspase 8 and PKR. In addition, the observation by others that viral FLIPs inhibit apoptosis triggered by Fas or TNFa (Irmler et al., 1997; Tschopp et al., 1998a,b) , and our observation that viral FLIPs also inhibit the activity of the antiviral molecule PKR, imply that these inhibitors play an important role during viral replication.
A general feature of death receptor pathways of apoptosis is that they conserve common mediators. Thus, the fact that FADD is involved in PKR-induced apoptosis, and that the only known FADD-dependent death receptors are Fas, TNFR1 and DR3 (Ashkenazi and Dixit, 1998; Yeh et al., 1998) links one of these receptors to the PKR apoptotic pathway. However, our results have discarded the involvement of both Fas and TNFR1 dependent pathways in PKR-induced apoptosis. Whether, DR3 (Yu et al., 1996) can mediate PKR-induced apoptosis remains to be known. However, recently some other stimuli inducing apoptosis through FADD have been described and shown to be independent of ligand-induced death receptor aggregation (Beltinger et al., 1999) and even to be independent of death receptors (Choi et al., 1998; Micheaux et al., 1999; Tang et al., 1999) . Thus, a possibility is that FADD could be involved in mediating apoptosis independently of death receptors. Elucidating the mechanism of FADD activation during PKR-induced apoptosis will require further investigation.
While PKR-induced apoptosis is initiated by a caspase 8 dependent cascade of apoptosis, the fact is that human Bcl-2 and a related molecule encoded by African Swine Fever Virus are able to prevent PKRinduced apoptosis (Brun et al., 1996; Lee et al., 1997) . These observations could be explained as follows. First, it is known that in certain cell types death receptor pathways of apoptosis dier in the contribution of the mitochondrial pathways of apoptosis (Scadi et al., 1998) , which could explain the inhibitory eect of Bcl-2 over apoptosis induced by PKR in HeLa cells (Lee et al., 1997) . Second, PKR could simultaneously activate dierent pathways, such as the caspase 8 death receptor pathway, and the caspase 9 pathway, which is Bcl-2 sensitive. Preliminary results analysing caspase 9 activation indicate that caspase 9 pathway is also involved in PKR-induced apoptosis but to a lesser extent than the caspase 8 pathway (Gil and Esteban, manuscript in preparation) .
In conclusion, in this work we have de®ned the involvement of molecules mediating death receptor pathways of apoptosis in PKR-induced cell death. A model explaining these observations is shown in Figure  8 . Our ®ndings revealed that PKR activates FADD, by an unknown mechanism, that this activation is independent of Fas or TNFR1, and that caspase 8 is activated and triggers the whole caspase cascade, leading to apoptosis.
Materials and methods
Reagents
Caspase 8 inhibitor 2 (Z-IETD-FMK), broad range caspase inhibitor (Z-VAD-FMK), and colorimetric caspase 3 substrate, (DEVD-pNA) were purchased from Calbiochem, and prepared as stock solutions in DMSO. 1997) was PCR ampli®ed from DNA obtained from a patient with MCV lesions, puri®ed as previously described (NunÄ ez et al., 1996) using the following set of primers, s159L 5'-CGG GAT CCC CAT GTC CGA CTC CAA G-3', and a159L 5'-CGG AAT TCT CAA GTC GTT TGC TCG GGG-3' including BamHI and EcoRI restriction sites respectively. PCR products were run on an agarose gel, band puri®ed, restricted with BamHI and EcoRI and cloned in pRSETC, digested with the same enzymes. The insert was sequenced, and was found to have the same sequence as described for MC 159L (Senkevich et al., 1996) . A Xpress epitope Cterminal tagged MC 159L coding fragment was cloned in the VV HA-insertional vector pHLZ (VaÂ zquez et al., 1998) .
cDNA encoding for human FADD DN (80 ± 208) extracted from pcDNA 3 AUF4 FADD DN vector (kindly provided by V Dixit) was ampli®ed by PCR using the following set of primers, sFADD DN 5'-CGG GAT CCA TGG ACG ACT TCG AGG C-3', and sFADD DN 5'-CGG ATA TCT CAG GAC GCT TCG GAG GTA GAT G-3'. PCR products were run on an agarose gel, band puri®ed, restricted with BamHI and EcoRV and cloned in pHLZ previously digested with SmaI and BglII.
Cell culture
African green monkey kidney cells, BSC-40 (ATCC CCL-26) were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% heat-inactivated new-born calf serum (NCS). Mouse 3T3 cells (ATCC CCL-92) were grown in DMEM supplemented with 10% foetal calf serum (FCS). HeLa cells (ECACC 85060701) were grown in DMEM supplemented with 10% NCS. After mock infection or viral adsorption, cells were maintained with DMEM supplemented with 2% NCS or 2% FCS. Mouse embryo ®broblasts (MEFs) were prepared by standard protocols from 13.5 day post-coitum lpr/lpr mouse embryos and from mouse embryos with similar genetic backgrounds. MEFs were infected two passages after the ®rst plating.
Viruses
The recombinant VV expressing IPTG-inducible PKR (called WR 68 K before, and VV PKR herein) was described previously (Lee et al., 1993) . VV FLIP a recombinant VV expressing a Xpress epitope N-terminal tagged MC159L coding fragment was generated by recombination of the pHLZ based vector pMC159L with VV (Western Reserve strain, WR) following standard procedures (Mackett et al., 1984) . VV FADD DN a recombinant VV expressing human FADD DN (aas 80 ± 208) was generated by recombination of the pHLZ based vector pFADD DN with VV (WR) following described procedures (Mackett et al., 1984) . VV PKR-FLIP and VV PKR FADD DN were generated by recombination of their respective pHLZ based vectors pMC159L or FADD DN with VV PKR. These viruses express IPTG-inducible PKR together with consitutively expressed MC 159L or FADD DN, respectively.
mRNA purification
Con¯uent mouse 3T3 cells (approximately 10 7 cells) treated as indicated were collected by scraping and low speed centrifugation and pellets were snap-frozen using methanoldry ice and kept frozen at 7808C until mRNA extraction. mRNAs were prepared using the Quickprep Micro mRNA Puri®cation Kit (Amersham Pharmacia) according to the manufacturer's instruction. This method is based on extraction with guanidinium thyocyanate and puri®cation with oligo (dT)-cellulose chromatography in a spin column.
Semiquantitative RT ± PCR
Equal amounts of mRNA were reverse-transcribed and ampli®ed by the polymerase chain reaction using the Superscript one-step RT ± PCR system (GIBCO-BRL) as indicated by the supplier. Primers used for the detection of Fas mRNA (5'-CAT CTC CGA GAG TTT AAA GCT GAG G-3' and 5'-GTT TCC TGC AGT TTG TAT TGC TGG TTG C-3'), which amplify a 413 bp fragment, were previously described . Control primers used for the detection of mRNA from the HPRT housekeeping gene (5'-GTT GGA TAC AGG CCA GAT TTG TTG-3' and 5'-GAT TCA ACT TGC GCT CAT CTT AGG C-3') amplify a 163 bp fragment. Ampli®cation conditions (25 cycles for HPRT and 30 cycles for Fas) were checked to be in the exponential phase of PCR. Ampli®cation reactions were made using a PTC-100 thermocycler (MJ Research) and analysed by 2 % agarose gel electrophoresis.
Caspase 3 and 8 activity assays
Caspase 8¯uorescent Apoalert assay was purchased from Clontech and used as indicated by the supplier. Brie¯y, 3610 6 cells were collected and lysed in lysis buer, supernatants were clari®ed and assayed for caspase 8 activity using the 50 mM IETD-AFC substrate. After 1 h incubation at 378C, cleaved substrate¯uorescence was determined usinḡ uorescence detection (400 nm excitation and 505 nm emission). For measurement of caspase 3 activity, 3610 6 cells were collected, lysed in lysis buer (150 mM KCl, 10% glycerol, 1 mM dithiothreitol, 5 mM magnesium acetate, 0.5% Nonidet P-40) and clari®ed by centrifugation. Equal amounts of supernatant and 26reaction buer (100 mM HEPES pH 7.5, 20% glycerol, 5 mM dithiothreitol, 0.5 mM EDTA) were mixed and assayed for caspase 3 activity using as substrate 200 mM DEVD-pNA from Calbiochem. Free pNA produced by caspase activity was determined by measuring absorbance at 405 nm.
Measurement of the extent of apoptosis
The Cell Death Detection Enzyme-linked immunosorbent assay (ELISA) kit (Roche) was used according to the manufacturer's instructions. This assay is based on the quantitative sandwich-enzyme-immunoassay-principle and uses mouse monoclonal antibodies directed against DNA and histones to estimate the amount of cytoplasmic histoneassociated DNA.
Antibodies and immunobloting
Polyclonal rabbit antibody speci®c for PKR was previously described (Gil et al., 1999) . FADD antibodies were from Pharmingen and Santa Cruz. Antibodies against the Xpress epitope were from Novagen. For blocking of the cytotoxic activity of FasL, a hamster anti-mouse FasL antibody (MFL3, Pharmigen) was used. The neutralizing anti-TNFa mAB, B13.2, was a generous gift from Manuel Fresno (CBMSO, Madrid) and has been described previously (Pimentel-MuinÄ os et al., 1994) . It was used in puri®ed form obtained from ascitic¯uid. Immunoblot analysis was performed by normal procedures, as previously described (Gil et al., 1999) .
FasL and TNFa antibody blocking assays
Brie¯y, MEFs or 3T3 cells (for the FasL antibody assay) or HeLa cells (for the TNFa antibody assay) were grown in 12-well plates and infected with the indicated virus (5 p.f.u./cell). After 1 h of viral adsorption, inoculum was removed, cells washed and media were added to cells containing 5 mM IPTG and antibodies at indicated concentrations. Cells were collected at selected times and processed for Cell Death Detection ELISA as described above. Each point shown in the ®gures represents, triplicate samples and at least two independent experiments were performed for each assay.
